Human THAP1 adenoviral particles

THAP1 (THAP domain containing 1) is a gene encoding a zinc finger transcription factor that plays a key role in regulating endothelial cell proliferation, apoptosis, and cell cycle progression. THAP1 is located on human chromosome 8p11.21 and contains a THAP domain, a conserved DNA binding motif that targets specific promoter regions to regulate gene expression. THAP1 mutations are associated with dystonia 6 (DYT6), a movement disorder characterized by involuntary muscle contractions, highlighting its importance in neurological function. In addition to its association with dystonia, THAP1 is involved in epigenetic regulation, transcriptional repression, and angiogenesis control, making it a gene of interest in basic research and therapeutic development.

Human THAP1 adenoviral particles are genetically engineered viral vectors designed to deliver the THAP1 gene to target cells for functional studies or potential gene therapy applications. These particles are based on adenovirus serotype 5 (Ad5) engineered to be replication-defective for improved safety. This adenoviral system provides high transduction efficiency in a variety of cell types, including primary and dividing cells, making it an ideal tool for overexpressing THAP1 in vitro or in vivo. Human THAP1 adenoviral particles are widely used to study the role of THAP1 in transcriptional regulation, neurological diseases, and vascular biology. Its application extends to preclinical models of dystonia and cancer research to explore the regulatory mechanisms of THAP1.